Skip to main content
Journal of Taibah University Medical Sciences logoLink to Journal of Taibah University Medical Sciences
. 2017 Jun 17;12(5):465–470. doi: 10.1016/j.jtumed.2017.05.006

Quality of life in transfusion-dependent thalassemia patients

Rizqallah A Alzahrani 1,, Oqab M Almutairi 1, Mohammed S Alghoraibi 1, Mshari S Alabdulwahed 1, Muath K Abaalkhail 1, Mashel K Alhawish 1, Mazi T Alosaimy 1
PMCID: PMC6695067  PMID: 31435280

Abstract

Objectives

Thalassemia is the most common genetic disorder in the Mediterranean region. Despite recent advances in the management of thalassemia, people living in developing countries do not receive satisfactory treatment. For such chronic conditions, not only is patients' survival important but their quality of life (QOL) is also important, which is primarily driven by psychological and social constraints. This study explores various factors that affect QOL in transfusion-dependent thalassemia patients.

Methods

This case control study included children with thalassemia major who received regular transfusions for the last five years. Controls were matched for age, gender and socio-economic status and included only healthy children. Different types of QOL were assessed using the World Health Organization (WHO) Quality of Life Assessment tool.

Results

Our study included 90 cases (8 dropouts) and 98 controls (0 dropouts), with an average age of 8.3 ± 4.4 in cases and 12.2 ± 4.7 in the control group. The total mean aggregate score of all patient questions was 82.04 ± 15.54; in the control group, the score was 87.86 ± 12.9. In nearly all factors, differences between cases and controls were most significant in males. There were no significant differences for the variables of physical pain, appearance and relations with others in both groups.

Conclusion

Although there was no significant difference in the QOL score in thalassemia children, a more significant difference was observed in male patents than in females. The implications of this finding must be explored in further case-control studies.

Keywords: Children, Physical pain, Psychological factors, Quality of life, Thalassemia major

Introduction

Worldwide, thalassemia is a serious public health problem because of the high prevalence extending from the Mediterranean and parts of Africa throughout the Middle East and the Indian sub-continent, Southeast Asia, Melanesia and into the Pacific Islands, ranging from 2% to 25%.1, 2, 3 Each year, 50,000 to 100,000 children die of thalassemia major in low- and middle-income countries, and approximately 7% of the world's population are carriers of a haemoglobin disorder.4, 5

Despite recent advances in thalassemia management, people living in developing countries do not receive satisfactory treatment.6 For such chronic conditions, not only patient survival is important but also their quality of life; psychological and social functioning are particular constraints.7, 8, 9, 10 The complications of thalassemia major are known to affect quality of life.11 According to the WHO definition, quality of life (QOL) is individuals' perceptions of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns.12

Beta thalassemia major is the most severe form of thalassemia, characterized by a severe microcytic, hypochromic iron deficiency.8 In paediatrics particularly, β-thalassemia major and its complications are associated with noteworthy psychological effects, emotional burdens, hopelessness, and trouble with social integration. Children with thalassemia demonstrate weakened abstract thinking and difficulties with language, consideration, memory, constructional/visual spatial abilities, and executive functions, all of which are more prominent in haemosiderotic subjects.13, 14 These children feel slightly different from their peers and develop negative thinking about life, show more anxiety and possess low self-esteem. Although their behavioural profile is similar to normal people's, a large number of these children demonstrate severe psychological deficits because of trouble following agonizing chelation.15, 16, 17, 18

Goal

The purpose of the study is to access the quality of life of transfusion-dependent thalassemia patients in the paediatric age group.

Materials and Methods

This case control study selected 98 children (cases) having thalassemia major who were receiving regular transfusions (once every 4–6 weeks minimum) for the last five years; 98 healthy controls from the schools were matched for age, gender and socio-economic status. Written informed consent was obtained from the parents of all participants younger than 18. Quality of life was assessed using the standardised tool WHO-QOL-BRF (Arabic Version) and was conducted in a tertiary care hospital, King Saud Medical City, Riyadh, KSA from March 2016 to February 2017. Ethical approval was granted by the Institutional Review Board under IRB registration number H-01-R-053.

From the total sample of 196 children, we eliminated the records of 8 cases because of inappropriate responses or because participants declined to respond properly after consent was granted. Hence, we had data from 188 records, analysed using SPSS 21.0, and the results are presented as descriptive and inferential statistics using Chi-square and t-test for scores of QOL BRF with a 5% level and tested for statistical significance.

Results

The average age in the control group was 12.2 ± 4.7 years and that of the case group was 10.3 ± 4.4 years. We observed that a majority (73.9) of the children had ‘good’ and ‘very good’ QOL with no statistically significant differences between these two groups. However, we observed a dissatisfaction (86.7) with overall general health in both groups.

The total score of all domains was 82.4 ± 5.54 in cases and 87.79 ± 2.91 in controls. Table 1 presents the responses to all determinants of the physical health domain with statistical significance except ‘feeling sufficiently energetic to perform daily life activates’ among the patients (p = 0.76). This result can be attributed to the fact that thalassemia patients have poor oxygen perfusion compared with normal children and thus feel more fatigued and less energetic. Table 2 presents the response to the components of the psychological health domain. We observed that 50 cases believed they led a meaningless life and 55.6 did not enjoy life compared with the controls, with statistical insignificance (p = 0.30). Figure 1 presents the distribution of participants for the environmental Health domain. Nearly 48.9 were satisfied with their healthy physical environment, 54.2 with health services and 42.5 felt safe, which was statistically significant (p = 0.01).

Table 1.

Domain 1: Response to physical health domain.

Status
p-Value Status
p-Value Status
p-Value
Case Control Case Control Case Control
Physical Pain Med Treatment Energy Daily Life
Not at all 9 44 0.000 3 1 0 3 3 0.765
A little 21 32 23 7 5 7
A moderate amount 28 16 26 26 27 28
Very much 21 2 33 38 37 40
An extreme amount 8 2 4 23 16 20
General Health Satisfied with Activities Able to Get Around
Very dissatisfied 3 2 0.000 1 0 0.000 2 5 0.001
Dissatisfied 18 7 13 3 20 7
Neither satisfied nor dissatisfied 22 16 32 21 21 16
Satisfied 40 44 35 42 38 40
Very satisfied 5 28 8 27 8 29

*Statistically significant at 0.05.

Table 2.

Domain 2: Response to psychological health domain.

Status
p-Value Status
p-Value Status
p-Value
Case Control Case Control Case Control
Satisfied with Sleep Satisfied with Capacity Enjoys Life
Very dissatisfied 3 2 0.000 7 0 0.009 2 2 0.067
Dissatisfied 18 7 4 5 12 6
Neither satisfied nor dissatisfied 22 16 13 15 36 40
Satisfied 40 44 44 42 34 30
Very satisfied 5 28 19 36 5 19
Bodily Appearance Meaningful Life Able to Concentrate
Not at all 14 5 0.004 1 0 0.308 3 0 0.022
A little 26 18 16 15 8 6
Moderately 28 27 30 27 31 17
Mostly 17 30 32 32 26 38
Completely 4 17 10 23 21 35

*Statistically significant at 0.05.

Figure 1.

Figure 1

(a) 1 to environmental health domain. (b) Response to environmental health domain.

Figure 2 presents children's satisfaction with Home environment, Health and Social care, Personal relationships and opportunities for recreation and leisure activities. There was a significant association observed among the groups and the components of the social domain. The scores of the various facets in each domain were tested using the student t-test. The overall mean score for the physical domain was 24.71 for controls and 23.06 among cases (p = 0.08). A low mean score of 18.97 (p = 0.18) was observed for the psychological domain and 21.42 (p = 0.057) for the environment domain compared to the control group, with no statistical significance. The social domain score of 6.1 was higher among the patients with significance (P = 0.000).

Figure 2.

Figure 2

Response to social health domain.

Discussion

Various aspects of quality of life, particularly those in the psychological and social domains, are generally ignored. This study probes the effect of frequent transfusions on various aspects of quality of life, including psychological and social aspects.

The WHO-QOL-BRF used in this study showed good validity in terms of content, internal consistency and reliability.18, 19 Although the tool is specified for adults, we used it on a paediatric population. The results indicated no significant difference between the quality of life of normal individuals and those receiving transfusions for thalassemia in both males and females in the physical, psychological and environmental domains. However, significant differences were observed in the social domain. It was surprising to note that the quality of life was reported to be better for children receiving transfusions than for healthy controls. A possible explanation for this could be that children with thalassemia receive more attention, making them feel better socially. Hongally20 also reported that the patients believed that the disease did not affect their family or social relationships. Ali SS21 also observed that thalassemia patients had significantly higher scores in the social domain. This finding was not consistent with studies by Pruthi, Naderi, and Ishtiaq.22, 23, 24

The findings by Behdani et al. and Ansari25, 26 and other reports from KSA varied widely from the results of our study, which reported significant differences in QOL in terms of psychological, social and health-related issues. The encountered differences can be attributed to the selected age groups and the diversity and/or differences in the socio-economic status of the studied subjects from various countries. Differences in the quality of health care services provided may also contribute to this wide difference. By contrast, the findings of Kehani et al. were similar to our findings in all domains.27 This difference can be explained by the age group selected. In a study by Ayoub et al.28 from western KSA, the quality of life among children with beta thalassemia major was affected by factors such as family income and a family history of thalassemia. Education appeared to increase patient functionality, and supportive measures may improve the quality of life in thalassemic patients.

Strengths and limitations of the study

There are few studies in which cases are compared to controls as they are in our study, particularly among paediatric patients. The majority of the published related studies were descriptive whereas this study used an analytic approach to justify its findings. However, the results are not intended to be generalized because of the limitation of the small sample size and the difficulty in collecting data from children.

Conclusion

It may be said that QOL for patients who must undergo transfusions for thalassemia is not similar to the QOL of the control group in all domains except for the domain of social health, in which the patients appear to have a better quality of life than normal individuals. This finding warrants the need for probing in more detail the aspects of quality of life in thalassemia children using a larger sample size and simpler questionnaire to elicit more factual responses.

Authors' contribution

Idea was conceived by RAA and OMA. Literature review was performed by RAA. MAS ad RAA developed study protocol while data collection which included survey from the participants along with data entry were performed by MA, M (Mauth) KA, M (Mazi) KA and MTA. MA and OMA did data analysis. MKA along with MSA drafted the first version of the paper, which was reviewed, initially by MKA, MSA, then finally MTA, and MKA Final did editing and submission to the journal by RAA.

Conflict of interest

The authors have no conflict of interest to declare.

Footnotes

Peer review under responsibility of Taibah University.

References

  • 1.Cappellini M.D., Cohen A., Eleftheriou A., Piga A., Porter J., Taher A. 2nd ed. Thalassaemia International Federation; Cyprus: 2008. Guidelines for the clinical management of thalassaemia. ISBN-13:978–9963-623-70-9. [PubMed] [Google Scholar]
  • 2.Weatherall D.J., Clegg J.B. Inherited hemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;78:704–712. [PMC free article] [PubMed] [Google Scholar]
  • 3.Roy T., Chatterjee S.C. The experiences of adolescents with thalassemia in West Bengal, India. Qual Health Res. 2007;17:85–93. doi: 10.1177/1049732306296400. [DOI] [PubMed] [Google Scholar]
  • 4.WHO . World Health Organization; Geneva: 2008. Management of haemoglobin disorders: report of a joint WHO-TIF meeting. [Google Scholar]
  • 5.Thavorncharoensap M., Torcharus K., Nuchprayoon I., Riewpaiboon A., Indaratna K., Ubol B. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disord. 2010;10:1. doi: 10.1186/1471-2326-10-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Caocci G., Efficace F., Ciotti F., Roncarolo M., Vacca A., Piras E., Littera R., Markous R., Collins G., Ciceri F., Mandelli F., Marktel S., La Nasa G. Health related quality of life in Middle Eastern children with beta-thalassemia. BMC Blood Disord. 2012;12:6. doi: 10.1186/1471-2326-12-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Telfer P., Constantinidou G., Andreou P., Christou S., Modell B., Angastiniotis M. Quality of life in thalassemia. Ann N YAcad Sci. 2005;1054:273–282. doi: 10.1196/annals.1345.035. [DOI] [PubMed] [Google Scholar]
  • 8.Mazzone L., Battaglia L., Andreozzi F., Romeo M., Mazzone D. Emotional impact in β-thalassemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers. Clin Pract Epidemiol Ment Health. 2009;5:5. doi: 10.1186/1745-0179-5-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Borgna-Pignatti C. The life of patients with thalassemia major. Haematologica. 2010;95(3):345–348. doi: 10.3324/haematol.2009.017228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dahui M., Hishamshan M.I., Rahman A.J.A., Aljuid S.M. Quality of life in transfusion- dependent thalassemia patients on desferrioxamine treatment. Singap Med J. 2009;50:794–799. [PubMed] [Google Scholar]
  • 11.Torcharus K., Pankaew T. Health-related quality of life in Thaithalassemic children treated with iron chelation. Southeast Asian J Trop Med Public Health. 2011;42:951–959. [PubMed] [Google Scholar]
  • 12.Gollo G., Savioli G., Balocco M., Venturino C., Boeri E., Costantini M. Changes in the quality of life of people with thalassemia major between 2001 and 2009. Patient Prefer Adherence. 2013;7:231–236. doi: 10.2147/PPA.S42133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Monastero R., Monastero G., Ciaccio C., Padovani A., Camarda R. Cognitive deficits in beta-thalassemia major. Acta Neurol Scand. 2000;102:162–168. doi: 10.1034/j.1600-0404.2000.102003162.x. [DOI] [PubMed] [Google Scholar]
  • 14.Beratis S. Psychosocial status in pre-adolescent children with β-thalassemia. J Psychosom Res. 1993;37:271–279. doi: 10.1016/0022-3999(93)90036-f. [DOI] [PubMed] [Google Scholar]
  • 15.Aydinok Y., Erermis S., Bukusoglu N., Yilmaz D., Solak U. Psychosocial implications of thalassemia major. Pediatr Int. 2005;47:84–89. doi: 10.1111/j.1442-200x.2004.02009.x. [DOI] [PubMed] [Google Scholar]
  • 16.Aydin B., Yaprak I., Akarsu D., Okten N., Ulgen M. Psychosocial aspects and psychiatric disorders in children with thalassemia major. Acta Paediatr Jpn. 1997;39:354–357. doi: 10.1111/j.1442-200x.1997.tb03752.x. [DOI] [PubMed] [Google Scholar]
  • 17.Saini A., Chandra J., Goswami U., Singh V., Dutta A.K. Case control study of psychosocial morbidity in beta thalassemia major. J Pediatr. 2007;150:516–520. doi: 10.1016/j.jpeds.2007.01.025. [DOI] [PubMed] [Google Scholar]
  • 18.Khairkar P., Malhotra S., Marwaha R. Growing up with the families of β-thalassaemia major using an accelerated longitudinal design. Indian J Med Res. 2010;132:428–437. [PubMed] [Google Scholar]
  • 19.Ohaeri J.U., Awadalla A.W. The reliability and validity of the short version of the WHO Quality of Life Instrument in an Arab general population. Ann Saudi Med. 2009;29:98–104. doi: 10.4103/0256-4947.51790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hongally C., Benakappa A.D., Reena S. Study of behavioral problems in multi-transfused thalassemic children. Indian J Psychiatry. 2012;54:333–336. doi: 10.4103/0019-5545.104819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ali S.S., Tarawah A.M., Al-Hawsawi Z.M., Zolaly M.A., Turkustani W. Comprehensive patient care improves quality of life in transfusion dependent patients with β-thalassemia. Saudi Med J. 2015;36(5):575–579. doi: 10.15537/smj.2015.5.10442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Pruthi G.K., Singh T.B. Psychosocial burden and quality of life in parents of children with thalassemia and cerebral palsy: a comparative study. Delhi Psychol. 2010;2:46–57. [Google Scholar]
  • 23.Naderi M., Hormozi M.R., Ashrafi M., Emamdadi A. Evaluation of mental health and related factors among patients with Beta-thalassemia major in South East of Iran. Iran J Psychiatry. 2012;7:47–51. [PMC free article] [PubMed] [Google Scholar]
  • 24.Ishtiaq R., Siddiqui S.H., Sajid R. Quality of life in Thalassemia patients. Int J Collab Res Intern Med Public Health. 2011;3(3):203. [Google Scholar]
  • 25.Behdani F., Badiee Z., Hebrani P., Moharreri F., Badiee A., Hajivosugh N. Psychological aspects in children and adolescents with major thalassemia: a case-control study. Iran J Ped. 2015;25(3):e322. doi: 10.5812/ijp.25(3)2015.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ansari S., Baghersalimi A., Azarkeivan A., Nojomi M., Hassanzadeh Rad A. Quality of life in patients with thalassemia major. Iran J Ped Hematol Oncol. 2014;4(2):57–63. [PMC free article] [PubMed] [Google Scholar]
  • 27.Kaheni S., Yaghobian M., Sharefzadah G.H., Vahidi A., Ghorbani H., Abderahemi A. Quality of life in children with Β-thalassemia major at center for special diseases. Iran J Ped Hematol Oncol. 2013;3(3):108–113. [PMC free article] [PubMed] [Google Scholar]
  • 28.Ayoub M.D., Radi A.S., Azab A.M., Abulaban A.A. Quality of life among children with beta-thalassemia major treated in Western Saudi Arabia. Saudi Med J. 2013;34(12):1281–1286. [PubMed] [Google Scholar]

Articles from Journal of Taibah University Medical Sciences are provided here courtesy of Taibah University

RESOURCES